Blood pressure decrease with ingestion of a soya product (kinako) or fish oil in women with the metabolic syndrome: Role of adiponectin and nitric oxide

British Journal of Nutrition

Volumn 108, Issue 8, 2012, Pages 1435-1442

  Simão, Andréa Name Colado ^a   Lozovoy, Marcell Alysson Batisti ^b   Bahls, Larissa Danielle ^a   Morimoto, Helena Kaminami ^a   Simão, Tathiana Name Colado ^b   Matsuo, Tiemi ^a   Dichi, Isaias ^a  

^a UNIVERSITY OF LONDRINA   (Brazil)

^b UNIVERSIDADE NORTE DO PARANÁ   (Brazil)

Author keywords

Adiponectin; Metabolic syndrome; n 3 Fatty acids; Nitric oxide; Soya

Indexed keywords

ADIPONECTIN; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; C REACTIVE PROTEIN; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; DOCOSAPENTAENOIC ACID; FISH OIL; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; ICOSAPENTAENOIC ACID; INTERLEUKIN 6; NITRIC OXIDE; OMEGA 3 FATTY ACID; TRIACYLGLYCEROL; TUMOR NECROSIS FACTOR ALPHA;

ABDOMINAL OBESITY; ADULT; ANTHROPOMETRY; ARTICLE; BLOOD PRESSURE REGULATION; CONTROLLED STUDY; DIET THERAPY; FEMALE; FOOD INTAKE; HUMAN; HYPERGLYCEMIA; HYPERTENSION; HYPERTRIGLYCERIDEMIA; MAJOR CLINICAL STUDY; METABOLIC SYNDROME X; PARALLEL DESIGN; PATIENT COMPLIANCE; RANDOMIZED CONTROLLED TRIAL; SOYBEAN; SYSTOLIC BLOOD PRESSURE;

ADIPONECTIN; ADULT; BIOLOGICAL MARKERS; BLOOD PRESSURE; DIETARY FATS; FATTY ACIDS, OMEGA-3; FEMALE; FISH OILS; HUMANS; INFLAMMATION; METABOLIC SYNDROME X; MIDDLE AGED; NITRIC OXIDE; PLANT PREPARATIONS; SOY FOODS;

EID: 84867718179     PISSN: 00071145     EISSN: 14752662     Source Type: Journal    
DOI: 10.1017/S0007114511006921     Document Type: Article

References (62)

1. Reaven GM (1988) Role of insulin resistance in human disease. Diabetes 37, 1595-1607.
2. Ford ES, Giles WH & Mokdad AH (2004) Increasing prevalence of the metabolic syndrome among U.S. adults. Diabetes Care 27, 2444-2449.
3. Grundy SM (2008) Metabolic syndrome pandemic. Arterioscler Thromb Vasc Biol 28, 629-636.
4. Deckelbaum RJ, Leaf A, Mozaffarian D, et al. (2008) Conclusions and recommendations from the symposium, beyond cholesterol: prevention and treatment of coronary heart disease with n-3 fatty acids. Am J Clin Nutr 87, Suppl., 2010S-2012S.
5. Sacks FM, Lichtenstein A, Van Horn L, et al. (2006) Soy protein, isoflavones and cardiovascular health. An American Heart Association Science Advisory for Professionals from the Nutrition Committee. Circulation 113, 1034-1044.
6. Appel LJ, Brands MW, Daniels SR, et al. (2006) Dietary approaches to prevent and treat hypertension: a scientific statement from the American Heart Association. Hypertension 47, 296-308.
7. Jenkins DJA, Kendall CWC, Jackson CJC, et al. (2002) Effects of high and low-isoflavone soyfoods on blood lipids, oxidized LDL, homocysteine, and blood pressure in hyperlipidemic men and women. Am J Clin Nutr 76, 365-372.
8. Yang G, Shu X-O, Jin F, et al. (2005) Longitudinal study of soy intake and blood pressure among middle-aged and elderly Chinese women. Am J Clin Nutr 81, 1012-1017.
9. He J, Gu D, Wu X, et al. (2005) Effect of soy bean protein on blood pressure: a randomized controlled trial. Arch Intern Med 143, 1-9.
10. Gelijnse JM, Giltay EJ, Grobbee DE, et al. (2002) Blood pressure response to fish oil supplementation: metaregression analysis of randomized trials. J Hypertens 20, 1493-1499.
11. Calder PC (2006) n-3 Polyunsaturated fatty acids, inflammation, and inflammatory diseases. Am J Clin Nutr 83, Suppl., 1505S-1519S.
12. Kadowaki T, Yamauchi T, Kubota, et al. (2006) Adiponectin and adiponectin receptors in insulin resistance, diabetes, and the metabolic syndrome. J Clin Invest 116, 1784-1792.
13. Azadbakht L, Kimiagar M, Mehrabi Y, et al. (2007) Soy consumption, markers of inflammation, and endothelial function. A cross-over study in postmenopausal women with the metabolic syndrome. Diabetes Care 30, 967-973.
14. Stirban A, Nandrean S, Götting C, et al. (2010) Effects of n-3 fatty acids on macro-and microvascular function in subjects with type 2 diabetes mellitus. Am J Clin Nutr 91, 808-813.
15. Simão ANC, Lozovoy MAB, Simão TNC, et al. (2010) Nitric oxide enhancement and blood pressure decrease in patients with metabolic syndrome using soy protein or fish oil. Arq Bras Endocrinol Metab 54, 540-545.
16. Jacobs DR Jr (2001) Executive summary of the third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and high blood cholesterol in adults (Adults Treatment Panel III). JAMA 285, 2486-2497.
17. Santana MB, Mandarino MG, Cardoso JR, et al. (2008) Association between soy and green tea (Camellia sinensis) diminishes hypercholesterolemia and increases total plasmatic antioxidant potential in dyslipidemic subjects. Nutrition 24, 562-568.
18. Pickering TG, Hall JE, Appel LJ, et al. (2005) Recommendations for blood pressure measurement in humans and experimental animals. Part 1: blood pressure measurement in humans: a statement for professionals from the Subcommittee of Professional and Public Education of the American Heart Association Council on High Blood Pressure Research. Hypertension 45, 142-161.
19. Chobanian AV, Bakris GC, Black HR, et al. (2003) Seventh Report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure. Hypertension 42, 1206-1252.
20. Guevara I, Iwanejko J, Dembińska-Kieć A, et al. (1998) Determination of nitrite/nitrate in human biological material by the simple Griess reaction. Clin Chim Acta 274, 177-188.
21. Navarro-Gonzálvez JA, Benayas CG & Arenas J (1998) Semiautomated measurement of nitrate in biological fluids. Clin Chem 44, 679-681.
22. Daamsgard CT, Frokiaer H, Andersen AD, et al. (2008) Fish oil combination with high or low intakes of linoleic acid lowers plasma triacylglycerols but does not affect other cardiovascular risk markers in healthy men. J Nutr 138, 1061-1066.
23. Maskarinec G, Oum R, Chaptman AK, et al. (2009) Inflammatory markers in a randomized soya intervention among men. Br J Nutr 101, 1740-1744.
24. Ait-Oufella H, Taleb S, Mallat Z, et al. (2011) Recent advances on the role of cytokines in atherosclerosis. Arterioscler Thromb Vasc Biol 31, 969-979.
25. Berg AH & Scherer PE (2005) Adipose tissue, inflammation and cardiovascular disease. Circ Res 96, 939-949.
26. Allison DB, Gadbury G, Schwartz LG, et al. (2003) A novel soy-based meal replacement formula for weight loss among obese individuals: a randomized controlled clinical trial. Eur J Clin Nutr 57, 514-522.
27. Deibert P, König D, Schmidt-Trucksaess A, et al. (2004) Weight loss without losing muscle mass in pre-obese and obese subjects induced by a high-soy-protein diet. Int J Obes 28, 1349-1352.
28. Ciubotaru I, Lee YS & Wander RC (2003) Dietary fish oil reduces C-reactive protein, interleukin 6, and triacylglycerol to HDL cholesterol ratio in postmenopausal women with HRT. J Nutr Biochem 14, 513-521.
29. Nagasawa A, Fukui K, Funahashi T, et al. (2002) Effects of soy protein diet on the expression of adipose genes and plasma adiponectin. Horm Metab Res 34, 635-639.
30. Charles C, Yuskavage J, Carlson O, et al. (2009) Effects of high-dose isoflavones on metabolic and inflammatory markers in healthy postmenopausal women. Menopause 16, 395-400.
31. Itoh M, Suganami T, Satoh N, et al. (2007) Increased adiponectin secretion by highly purified eicosapentaenoic acid in rodent models of obesity and human obese subjects. Arterioscler Thromb Vasc Biol 27, 1918-1925.
32. Shirai N & Suzuki H (2008) Effects of simultaneous intake of fish oil and green tea extracts on plasma, glucose, insulin, C-peptide, and adiponectin on liver lipid concentrations in mice fed low-and high-fat diets. Ann Nutr Metab 52, 241-249.
33. Lara JJ, Economou M, Wallace AM, et al. (2007) Benefits of salmon eating on traditional and novel vascular risk factors in young, non-obese healthy subjects. Atherosclerosis 193, 213-221.
34. Banga A, Unal R, Tripathi P, et al. (2009) Adiponectin translation is increased by the PPARy agonists pioglitazone and v-3 fatty acids. Am J Physiol Endocrinol Metab 296, E480-E489.
35. Tao L, Wang Y, Gao E, et al. (2010) Adiponectin-an indispensable molecule in rosiglitazone cardioprotection following myocardial infarction. Circ Res 106, 409-417.
36. Kratz M, Swarbrick MM, Callahan HS, et al. (2008) Effects of dietary n-3 polyunsaturated fatty acids on plasma total and high-molecular-weight adiponectin concentrations in overweight to moderately obese men and women. Am J Clin Nutr 87, 347-353.
37. Kabir M, Skurnik G, Naour N, et al. (2007) Treatment for 2mo with n-3 polyunsaturated fatty acids reduces adiposity and some atherogenic factors but not improve insulin sensitivity in women with type 2 diabetes: a randomized controlled study. Am J Clin Nutr 86, 1670-1679.
38. Barbosa DS, Simão ANC & Dichi I (2010) Use of olive oil in patients with arthritis rheumatoid. In Olives and Olive Oil in Health and Disease Prevention, 1st ed., pp. 1057-1064 [VR Preedy and RR Watson, editors]. Oxford: Elsevier.
39. Fernández-Real J-M, Vendrell J & Ricart W (2005) Circulation adiponectin and plasma fatty acid profile. Clin Chem 51, 603-609.
40. Hall WL, Formanuik NL, Harnpanich D, et al. (2008) A meal enriched with soy isoflavones increases nitric oxidemediated vasoldilatation in healthy postmenopausal women. J Nutr 138, 1288-1292.
41. Squandrito F, Altavilla D, Squandrito G, et al. (2000) Genistein supplementation and estrogen replacement therapy improves endothelial dysfunction induced by ovariectomy in rats. Cardiovasc Res 45, 454-462.
42. Li SH, Liu XX, Bai YY, et al. (2010) Effect of oral isoflavone supplementation on endothelial function in postmenopausal women: a meta-analysis of randomized placebo-controlled trials. Am J Clin Nutr 91, 480-486.
43. Doshi SN, Naka KK, Payne N, et al. (2001) Flow-mediated dilatation following wrist and upper arm occlusion in humans: the contribution of nitric oxide. Clin Sci 101, 629-635.
44. Goodfellow J, Bellamy MF, Ramsey MW, et al. (2000) Dietary supplementation with marine omega-3 fatty acids improves systemic large artery endothelial function in subjects with hypercholesterolemia. J Am Coll Cardiol 35, 265-270.
45. Jung UJ, Torrejon C, Tighe AP, et al. (2008) N-3 Fatty acids and cardiovascular disease: mechanisms underlying beneficial effects. Am J Clin Nutr 87, Suppl., 2003S-2009S.
46. Kelley DS, Siegel D, Fedor DM, et al. (2009) DHA supplementation decreases serum C-reactive protein and other markers of inflammation in hypertriglyceridemic men. J Nutr 139, 495-501.
47. Schmitt CA & Dirsch VM (2009) Modulation of endothelial nitric oxide by plant-derived products. Nitric Oxide 21, 77-91.
48. Nyby MD, Matsumoto K, Yamamoto K, et al. (2004) Dietary fish oil prevents vascular dysfunction and oxidative stress in hyperinsulinemic rats. Am J Hypertens 18, 213-219.
49. Erdman JW Jr (2000) AHA Science Advisory: soy protein and cardiovascular disease: a statement for healthcare professionals from the Nutrition Committee on the AHA. Circulation 10, 2555-2559.
50. Bai Y, Lun S, Yang T, et al. (2009) Increase in fasting vascular endothelial function after short-term oral L-arginine is effective when baseline flow-mediated dilatation is low: a meta-analysis of randomized trials. Am J Clin Nutr 89, 77-84.
51. Azadbakht L, Kimiagar M, Mehrabi Y, et al. (2007) Soy inclusion in the diet improves features of the metabolic syndrome: a randomized crossover study in postmenopausal women. Am J Clin Nutr 85, 735-741.
52. Ueshima H, Stamler J, Elliot P, et al. (2007) Food omega-3 fatty acid intake of individuals (total, linolenic acid, longchain) and their blood pressure INTERMAP study. Hypertension 50, 313-319.
53. Goldstein BJ & Scalia R (2004) Adiponectin: a novel adipokine linking adypocytes and vascular function. J Clin Endocrinol Metab 89, 2563-2568.
54. Zhu W, Cheng KKY, Vanhoutte PM, et al. (2008) Vascular effects of adiponectin: molecular mechanisms and potential therapeutic intervention. Clin Sci 114, 361-374.
55. Tan KCB, Xu A, Chow WS, et al. (2004) Hypoadiponectinemia is associated with impaired endothelium-dependent vasodilatation. J Clin Endocrinol Metab 89, 765-769.
56. Li R, Wang WQ, Zhang H, et al. (2007) Adiponectin improves endothelial function in hyperlipidemic rats by reducing oxidative/nitrative stress and differential regulation of eNOS/iNOS activity. Am J Physiol Endocrinol Metab 293, E1703-E1708.
57. Ohashi K, Kihara S, Ouchi N, et al. (2006) Adiponectin replenishment ameliorates obesity-related hypertension. Hypertension 47, 1108-1116.
58. Ziemke F & Mantzoros CS (2010) Adiponectin in insulin resistance: lessons from translational research. Am J Clin Nutr 91, Suppl., 258S-261S.
59. Shimabukuro M, Higa N, Asahi T, et al. (2003) Hypoadiponectinemia is closely linked to endothelial dysfunction in men. J Clin Endocrinol Metab 88, 3236-3240.
60. Ouchi N, Ohishi M, Kihara S, et al. (2003) Association of hypoadiponectinemia with impaired vasoreactivity. Hypertension 42, 231-234.
61. Hermann M, Flammer A & Lüscher TF (2006) Nitric oxide in hypertension. J Clin Hypertens 8, Suppl. 4, 17-29.
62. Howe PRC (1997) Dietary fats and hypertension: focus on fish oil. Ann N Y Acad Sci 827, 339-352.